- Posts: 333
- Thank you received: 31
one of the new special drugs it launched last yr was to reduce side effect from chemotherapy, which I believe has strong prospect. It is planning to launch a few more drugs in 2013. Hope it will turn out to be a super good yr for Starpharm and also Eratat
I hv added starpharm into my stock watchlist. Need to observe n dig up more info first.
Hi qwerty89, I always look out for positive changes in companies that are not still not doing well and also the shareholders behind them that will drive the share price when more positive results are announced.
Typically for this type of nanocap, it takes a really strong catalyst (eg. killer product, strong dividend increase, etc.) for things to work out.
Look at Fujian Zhenyun. Profitable business, huge cashpile, even has a special audit back in 2011 to ascertain cash is real.
Current situation: still languishing with NAV of $1.44 vs market price of $0.18
Of course, I haven't looked in-depth at Starpharm yet, but I would say the value discrepancy must be really huge for me to want to jump in.
On shareholders, the new CEO has bought 31m shares at 5c/share from ex-CEO in Jan 13. And, I noted one famous local investor, Bobby Lim, has accumulated some shares in the company.
|Geo Energy Res||0.375||0.010|
|Southern Alliance Mining||0.380||-0.060|
We have 2159 guests and no members online